Unethical pharmaceutical practices

Criminal activities of pharmacists
Illegal dispensing of drugs
Pharmaceutical malpractice
Corruption in pharmaceutical industry
Blackmail involving drugs
Unfair pharmaceutical practices
Fraudulent pharmaceutical practices

Nature

Unethical pharmaceutical practices refer to actions by companies or individuals in the pharmaceutical industry that violate ethical standards, endanger public health, or prioritize profit over patient welfare. These practices include data falsification, misleading marketing, bribery, inadequate safety testing, price gouging, and withholding negative information about drugs. Such conduct can harm patients, erode public trust, and undermine healthcare systems. Regulatory authorities worldwide strive to detect and penalize these malpractices; however, enforcement challenges persist, making unethical pharmaceutical behavior a persistent global problem with significant ethical, legal, and health-related implications.

Incidence

In 2009, Pfizer (and its subsidiary Pharmacia & Upjohn Company) paid US$ 2.3 billion to settle criminal and civil liabilities for illegal promotion of their pharmaceutical products. The amount included payment of more than $102 million in civil settlement to six whistleblowers of the company’s fraudulent practices.

In Brazil, thousands of children were born with deformities due to misinformation and ignorance about the use of the drug Thalidomide as a cure for leprosy.

Claim

"Everybody is out there begging for money. Nobody has any money. The only ones who do are the big international corporations, and they have lots of money. They give grants for research, pay doctors and researchers thousands of dollars to travel around, speak at conferences and establish educational programs, all in order to make profits for their products. The safety trials are supposedly third-party and independent, but the money won’t keep coming unless they support your drug, unless they say what you want them to say. Everybody knows that this is how things work. Only the public doesn’t know it." (Dr Peter Rost, former vice-president of Pfizer and author of The Whistleblower, Confessions of a Healthcare Hitman.)

Counter-claim

Claims about unethical pharmaceutical practices are often exaggerated. Strict regulations and oversight already govern the industry, ensuring safe and effective medications reach the public. Isolated incidents do not represent the norm, and sensationalizing rare cases distracts from the life-saving work pharmaceutical companies perform daily. Constant suspicion only hampers scientific progress and undermines public trust unnecessarily. Ultimately, this topic is not a significant problem compared to the industry’s overall positive global impact.